TrialEuropean journal of nuclear medicine and molecular imaging2018

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

Norbert Galldiks et al.PubMed ↗Publisher ↗

No numbers read from the abstract.